About: Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 May 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu en mayu de 2019 (ast) scientific article published on 15 May 2019 (en) наукова стаття, опублікована 15 травня 2019 (uk)
publication date	wds:Q92038498-97F860C9-1373-49E7-B105-48854701BC5F
publication date	2019-05-15 00:00:00Z (xsd:dateTime)
cites work	wds:Q92038498-0609A105-2BB2-4C8E-B9B1-B08DC27D37C7 wds:Q92038498-0917E248-5A27-4743-964C-3D70A921CB93 wds:Q92038498-0AFA4048-4483-42E6-B771-F5A6910466C7 wds:Q92038498-1451E6E9-34EA-4F90-9232-37BD888A71CB wds:Q92038498-28D47EC5-E23C-499A-91B6-E094C13B16C6 wds:Q92038498-41BC8995-8205-48D3-9D60-74979A575D20 wds:Q92038498-4830ACAC-A4A1-43FF-A629-FDC7E354C858 wds:Q92038498-5E15BC32-95F7-402C-A09B-C3173B8834DC wds:Q92038498-618BE2D5-6688-4C2F-9E68-6C0AF914EDF7 wds:Q92038498-647E3DE0-07CA-484E-ACC9-343F506176F5 wds:Q92038498-668DCFD3-1795-47A6-8B2B-D1453D22CAD8 wds:Q92038498-72FC6BF7-FB9C-47FF-AD74-833234DB518A wds:Q92038498-75A4B901-F205-4FAC-A3D5-F6F989E7ECDA wds:Q92038498-7E273E28-5659-4978-B0BE-50987B4C75CE wds:Q92038498-83D2ABC4-23B1-4700-B4F7-C716979D27E7 wds:Q92038498-85D6FC8F-91D6-4106-AE6A-68FB6EDC6F33 wds:Q92038498-8C39FEA8-2160-4E00-BCAC-0160E0BAED30 wds:Q92038498-8FD0874F-7F11-44C0-8CCB-2F1D3025877D wds:Q92038498-93BC40D5-A9CF-41E7-9032-6FFF00F8EE95 wds:Q92038498-94D5643D-000A-4A04-8966-9F2CE2DAC1B8 wds:Q92038498-98B3B6ED-8107-4116-9605-7EC59F8787F1 wds:Q92038498-A6853879-5C9C-4C6C-B7EF-6C4961B52497 wds:Q92038498-AAF86163-2282-40F8-B90D-7BE06BAF816D wds:Q92038498-B0478A78-DAD6-4C84-9CA4-C9C802F8EB1A wds:Q92038498-C2D8E022-3C8C-41D2-A40C-1528189C287F wds:Q92038498-D80E1746-2C04-42EF-814A-AF3B54255CB1 wds:Q92038498-F26EC2FD-5C21-4B69-9FFB-82EC1B39A886 wds:Q92038498-F37715DB-170D-49C0-A40E-EE4904A89F01 wds:Q92038498-FC9802F6-800B-48F7-B580-2CF2B90B23B4 wds:Q92038498-FE89C361-BC08-40AE-A98D-F1FFD9DA750B
cites work	Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Genetics and cytogenetics of multiple myeloma: a workshop report. Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials IMWG consensus on risk stratification in multiple myeloma Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome. Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy Clinical and biologic implications of recurrent genomic aberrations in myeloma The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients. Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter? Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor? Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma. Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma. Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
author name string	wds:Q92038498-08329965-6B84-4730-8373-D9C91EF6DAEA wds:Q92038498-2D7ACB24-90B2-47BD-9E99-AFD1A8E32136 wds:Q92038498-2E2B8B6D-F4A7-4B79-B3A6-781C59F47D56 wds:Q92038498-578D1F20-2865-4EA1-9485-56DB887F0135 wds:Q92038498-6CE23EB1-5334-4991-B4A0-7D231A03A958 wds:Q92038498-76685F31-BB08-4E7C-BFDC-5A15B45145B0 wds:Q92038498-A0D38A6B-8965-478F-867E-5F94A6DE7EA0 wds:Q92038498-BC13ED96-3C11-4F7D-A327-210AC2A0F267 wds:Q92038498-F1F37FFB-603B-4534-9776-4EAC16DED321 wds:Q92038498-F5611330-BF37-46D6-B4AD-B198EB0132E1
author name string	Xavier Leleu Bruno Royer Cyrille Hulin Valérie Lauwers-Cances Hervé Avet-Loiseau Elodie Tournay François Lifermann Philippe Collet Jean Fontan Claudine Sohn
rdfs:label	Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma (en) Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma (nl)
skos:prefLabel	Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma (en) Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma (nl)
name	Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma (en) Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma (nl)
author	wds:Q92038498-0709D8C2-5638-46EE-BE1C-D0A3671DCFA6 wds:Q92038498-07F15D13-07E7-4D88-AD72-40F591FF4D8E wds:Q92038498-08126E2A-CED0-4872-93A8-6C6F32489663 wds:Q92038498-14EA8F5C-94F3-4F6E-9EAF-9DC11865365E wds:Q92038498-2BB63B25-4918-44F2-BEB7-19CD139B46E5 wds:Q92038498-2E8FB5D6-1107-424A-9F9C-9A4695EDA1A6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software